Trial intelligence / Profile preview

Bioavailability of Symbicort vs Seretide in COPD and Healthy Volunteers

NCT00379028Phase 4Completed

Sponsor
AstraZeneca
Start
Sep 2006
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Sep 2006; status: completed.

02

Drugs

budesonide
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00379028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00379028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call